Netflix co-CEO grilled by senators as Warner Bros. deal sparks monopoly concerns: ‘One platform to rule them all'
nypost.com
Want to monitor MAIA?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor MAIAmaia biotechnology, inc. is a targeted therapy, immune-oncology company, focused on development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. a privately-held company based in chicago, maia is led by a passionate, principled and highly experienced management team with significant drug development experience, committed to advancing promising agents into trials in humans clinical trials.